Page last updated: 2024-10-26

3,4-dihydroxybenzohydroxamic acid and Carcinoma, Renal Cell

3,4-dihydroxybenzohydroxamic acid has been researched along with Carcinoma, Renal Cell in 1 studies

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Osako, Y1
Yoshino, H1
Sakaguchi, T1
Sugita, S1
Yonemori, M1
Nakagawa, M1
Enokida, H1

Other Studies

1 other study available for 3,4-dihydroxybenzohydroxamic acid and Carcinoma, Renal Cell

ArticleYear
Potential tumor‑suppressive role of microRNA‑99a‑3p in sunitinib‑resistant renal cell carcinoma cells through the regulation of RRM2.
    International journal of oncology, 2019, Volume: 54, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Drug Re

2019